NEW YORK, May 5 /PRNewswire-Asia/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today announced the Company's participation in the following conferences:
-- Merrill Lynch Asian STARS 2009, held May 6-8 at the Ritz Carlton in
Singapore. Ms. Lily Li, the Company's COO and CFO, is scheduled to
meet with institutional investors and to participate in a panel
discussion entitled "Asian Healthcare Sector - Immune to Economic
Downturn?"
-- Credit Suisse China Healthcare Tour, held the week of May 18th in China.
-- Oppenheimer 3rd Annual China Dragon Call Conference, held May 19-21 at
300 Madison Avenue in New York City. Management is currently
scheduled to meet with institutional investors and to present at 1:20
pm ET on Wednesday, May 20, 2009.
For further details, please contact your respective sales representative.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a China-based pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.
